No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Citadel
$90.8M
added
Bridgewater
$89.3M
added
Sells/Trims (1)
Qube Research
$75.3M
sold
No tracked top-trader positions in SHEL as of Oct 24, 08:46 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$3.23 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
$3.55 to $3.95
Revenue expected
6 analysts
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $3.52 / $3.23Alpha Vantage | +8.98% beat | $94.66B No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $2.44 / $2.21Alpha Vantage | +10.41% beat | $69.69B No estimate | Unavailable |
| Dec 31, 2025 | Feb 5, 2026 | $1.14 / $1.29Alpha Vantage | -11.63% miss | $64.00B No estimate | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $1.86 / $1.74Alpha Vantage | +6.90% beat | $68.15B No estimate | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $1.44 / $1.27Alpha Vantage | +13.39% beat | $65.41B No estimate | Unavailable |
| Mar 31, 2025 | May 2, 2025 | $1.84 / $1.61Alpha Vantage | +14.29% beat | $69.23B No estimate | Unavailable |
| Dec 31, 2024 | Jan 30, 2025 | $1.20 / $1.49Alpha Vantage | -19.46% miss | $66.28B No estimate | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | Unavailable | - | $71.09B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $68.15B | $64.00B | $69.69B | $94.66B |
| Cost of what it sold | $56.58B | $54.00B | $56.26B | $76.19B |
| Gross profit | $11.58B | $10.00B | $13.43B | $18.48B |
| What it spent | ||||
| Research and development | $409.0M | $297.6M | $167.0M | $277.0M |
| Sales and admin | $3.26B | $3.43B | $2.80B | $2.91B |
| Other operating costs | $175.0M | -$125.8M | $98.0M | $110.0M |
| Total operating expenses | $3.84B | $3.60B | $3.07B | $3.30B |
| What was left | ||||
| Operating profit | $7.73B | $12.13B | $10.37B | $15.18B |
| Interest on debt | $1.28B | $1.19B | $1.47B | $1.11B |
| Profit before tax | $7.92B | $6.89B | $9.33B | $15.75B |
| Tax | $2.50B | $2.71B | $3.57B | $4.95B |
| Net profit | $5.32B | $4.13B | $5.69B | $10.82B |
| EBITDA | $15.03B | $12.13B | $16.54B | $22.43B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace